KWELLADA-P LOTION 5 %
PERMETHRIN : 5 % · DIN 02231348 · MEDTECH PRODUCTS INC
Health Canada status: MARKETED
What is KWELLADA-P LOTION?
KWELLADA-P LOTION 5 % contains PERMETHRIN : 5 %. It is listed in the Health Canada Drug Product Database under DIN 02231348, held by MEDTECH PRODUCTS INC, supplied as LOTION for TOPICAL administration. Health Canada currently lists it as marketed, status dated 15-Feb-2013. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
What is KWELLADA-P LOTION used for?
Kwellada-P Lotion is indicated for the treatment of scabies Sarcoptes scabiei. One application of Kwellada-P Lotion is usually adequate to eradicate the infestation of scabies. If new lesions appear or live scabies mites are seen, a second treatment can occur seven to ten days after the initial treatment.
Authorized indication as written in the Health Canada product monograph. For healthcare professionals and licensed purchasers; this is not medical advice.
Product details and regulatory record
| DIN | 02231348 |
|---|---|
| Brand name | KWELLADA-P LOTION |
| Generic / active ingredient | PERMETHRIN : 5 % |
| Manufacturer | MEDTECH PRODUCTS INC |
| Strength | 5 % |
| Dosage form | LOTION |
| Route of administration | TOPICAL |
| Schedule | NON-PRESCRIPTION DRUGS |
| ATC code | P03AC04 PERMETHRIN |
| AHFS class | 84:04.12 |
| Biosimilar | No |
| Health Canada status | MARKETED |
| Status date | 15-Feb-2013 |
| Original market date | 1997-10-16 00:00:00 |
How is it stored and handled?
between 15° and 30°C
How is it supplied?
plastic bottles containing 100 mL lotion
What can be used instead?
Other Canadian products sharing ATC code P03AC04 PERMETHRIN. 4 of 5 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| KWELLADA-P CRÈME RINSE | 1 % | LIQUID | MEDTECH PRODUCTS INC | MARKETED | DIN 02231480 |
| NIX CREME RINSE | 1 % | CREAM | INSIGHT PHARMACEUTICALS, LLC | MARKETED | DIN 00771368 |
| NIX DERMAL CREAM | 5 % | CREAM | HALEON CANADA ULC | MARKETED | DIN 02219905 |
| NIX DERMAL CREAM 5% | 5 % | CREAM | BURROUGHS WELLCOME INC., CONSUMER PROD DIVISION | CANCELLED POST MARKET | DIN 01943154 |
Who else supplies PERMETHRIN worldwide?
Nexara tracks national medicine registries and published price lists across multiple markets. PERMETHRIN appears in 21 registered pack listings across 7 markets, published on 6 different national price bases. Where a Canadian route is closed, that is where an alternative route of supply starts — subject to the import rules in both countries.
Registered listings are not stock. Ask us to confirm what can actually be sourced for your order.
How can I get it?
Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.